Raj Chovatiya, MD, PhD, MSCI
Associate Professor, Rosalind Franklin University of Medicine and Science Chicago Medical School; Founder and Director, Center for Medical Dermatology + Immunology Research, Chicago, IL
Midwest/East_North_Central, IL
Disclosure
Consultant - AbbVie, Acelyrin, Almirall, Alumis, Amgen, AnaptysBio, Apogee Therapeutics, Arcutis Biotherapeutics, Argenx, Astria Therapeutics, Avalere Health, Beiersdorf, BioCryst Pharmaceuticals, Blueprint Medicines, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Celldex Therapeutics, CLn Skin Care, Dermavant, DKSH, Eli Lilly and Company, EMD Serono, Enveda Therapeutics, EPI Health, Formation Bio, Forte Biosciences, Galderma, Genentech, GSK, Incyte, Imagene Bio, Immunocore, Indero, Johnson & Johnson, Kenvue, LEO Pharma, L’Oréal, Navigator Medicines, Nektar Therapeutics, Nia Health, North Immunology, Novan, Novartis, Opsidio, Organon, Pfizer, PPD Development, Propeller Bio, RAPT Therapeutics, Regeneron, Sanofi, Sitryx, SUN Pharma, Takeda, TRex Bio, UCB, WCG, Zai Lab, ZenZema, Zuellig Pharma